首页 > 最新文献

International Journal of Pharmacy Practice最新文献

英文 中文
Community-based HbA1c testing programme for early detection of undiagnosed diabetes in community pharmacy.
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-12 DOI: 10.1093/ijpp/riaf005
Aiko Shono, Aki Morihiro, Nobue Harada, Xerxes Seposo, Wataru Mimura, Shu-Ling Hoshi, Naoya Yahagi, Seiko Miyazaki, Masahide Kondo

Objective: Testing with fingertip blood sampling, including HbA1c testing, has been available in community pharmacies in Japan since 2014. In 2016, the Mihara Pharmacy Association in Hiroshima Prefecture, in collaboration with the Mihara municipal government, developed a community programme that utilized the walk-in HbA1c test that could be offered by participating community pharmacies. The aim of this study was to assess whether the new programme could detect undiagnosed DM in the community and to compare groups who had and had not accessed the SHCG programme among SHCG eligible participants.

Method: The programme includes pharmacist advice following participants conducted Hba1c testing in the pharmacy, and completing a questionnaire to collect self-reported personal data including lifestyle, demography, height, weight, and blood pressure. All those accessing the programme were included. We analysed data from fiscal years 2016 to 2018, obtained retrospectively from the questionnaires.

Key findings: The participants aged 40-74 years who were the target of a national health check programme represented 73.7% of the 1933 total unique participants. Approximately 40% of these participants did not undergo routine checkups, 23.8% had HbA1c scores ≥5.6%, and 2.7% had HbA1c scores ≥6.5%.

Conclusions: The walk-in HbA1c community testing programme provided an opportunity to test the diabetes mellitus risk of residents, especially those who have missed their routine checkups. If the community programme were adopted widely, more undiagnosed populations at risk for diabetes mellitus could be detected in the early stages and the use of community resources such as pharmacists and pharmacies would be utilized.

{"title":"Community-based HbA1c testing programme for early detection of undiagnosed diabetes in community pharmacy.","authors":"Aiko Shono, Aki Morihiro, Nobue Harada, Xerxes Seposo, Wataru Mimura, Shu-Ling Hoshi, Naoya Yahagi, Seiko Miyazaki, Masahide Kondo","doi":"10.1093/ijpp/riaf005","DOIUrl":"https://doi.org/10.1093/ijpp/riaf005","url":null,"abstract":"<p><strong>Objective: </strong>Testing with fingertip blood sampling, including HbA1c testing, has been available in community pharmacies in Japan since 2014. In 2016, the Mihara Pharmacy Association in Hiroshima Prefecture, in collaboration with the Mihara municipal government, developed a community programme that utilized the walk-in HbA1c test that could be offered by participating community pharmacies. The aim of this study was to assess whether the new programme could detect undiagnosed DM in the community and to compare groups who had and had not accessed the SHCG programme among SHCG eligible participants.</p><p><strong>Method: </strong>The programme includes pharmacist advice following participants conducted Hba1c testing in the pharmacy, and completing a questionnaire to collect self-reported personal data including lifestyle, demography, height, weight, and blood pressure. All those accessing the programme were included. We analysed data from fiscal years 2016 to 2018, obtained retrospectively from the questionnaires.</p><p><strong>Key findings: </strong>The participants aged 40-74 years who were the target of a national health check programme represented 73.7% of the 1933 total unique participants. Approximately 40% of these participants did not undergo routine checkups, 23.8% had HbA1c scores ≥5.6%, and 2.7% had HbA1c scores ≥6.5%.</p><p><strong>Conclusions: </strong>The walk-in HbA1c community testing programme provided an opportunity to test the diabetes mellitus risk of residents, especially those who have missed their routine checkups. If the community programme were adopted widely, more undiagnosed populations at risk for diabetes mellitus could be detected in the early stages and the use of community resources such as pharmacists and pharmacies would be utilized.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143399094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nausea and vomiting in pregnancy: a cross-sectional study of community pharmacists in the UK. 妊娠恶心和呕吐:对英国社区药剂师的横断面研究。
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-07 DOI: 10.1093/ijpp/riae057
Bradley Payne, Olivia Righton, Melanie Nana, Sarah Chapman, Catherine Williamson, Shivali Lakhani, Marsha Alter, Zoe Bell, Angela C Flynn

Objectives: To assess the content and frequency of advice community pharmacists (CPs) provide to pregnant women with nausea and vomiting, their confidence in providing advice, and their knowledge of the safety of medication used to manage the condition.

Methods: An online questionnaire of closed- and open-ended questions was distributed to CPs in the UK in May 2023. Closed-ended questions were analysed quantitatively, and conventional content analysis was utilised for open-ended responses.

Key findings: One hundred and eighty-one respondents completed the questionnaire, 24 responses were excluded, leaving data from 157 available for analysis. The majority (90.4%) of participants reported having experience in providing advice on nausea and vomiting with varying levels of confidence. Advice provided included using over-the-counter products, lifestyle modifications, reassurance, medication advice, and referring to other healthcare professionals. Knowledge of first-line antiemetics considered safe in pregnancy varied; cyclizine was correctly identified as safe during pregnancy by 57.3%, followed by 37.6% for promethazine and 31.2% for prochlorperazine. Self-reported confidence and having experience providing advice were related to higher medication safety identification rates. Five percent of participants reported previous training on the condition, while 70% reported wanting further education, preferably delivered via an online medium.

Conclusions: This study showed that although 90% of CPs provide advice on nausea and vomiting in pregnancy, their medication safety knowledge varied. The majority of CPs reported wanting further education that would ensure women could access reliable information and evidence-based advice to optimise management of the condition.

目的评估社区药剂师(CPs)向患有恶心和呕吐的孕妇提供建议的内容和频率、他们提供建议的信心以及他们对控制恶心和呕吐的药物安全性的了解:方法:2023 年 5 月,向英国的社区药剂师发放了一份包含封闭式和开放式问题的在线问卷。对封闭式问题进行了定量分析,对开放式回答进行了常规内容分析:181 名受访者完成了问卷调查,其中 24 份答复被排除在外,剩下 157 份的数据可供分析。大多数参与者(90.4%)表示有提供恶心和呕吐建议的经验,但自信程度不一。所提供的建议包括使用非处方产品、改变生活方式、安抚、药物治疗建议以及转介给其他医护人员。对孕期安全的一线止吐药的了解程度各不相同;57.3%的人正确地认为环嗪类药物在孕期是安全的,其次是37.6%的人认为异丙嗪类药物在孕期是安全的,31.2%的人认为丙氯丙嗪类药物在孕期是安全的。自我报告的自信心和提供建议的经验与较高的用药安全识别率有关。5%的参与者表示以前接受过相关培训,而70%的参与者表示希望接受进一步的教育,最好是通过在线媒体提供:本研究表明,尽管 90% 的 CPs 提供了有关妊娠恶心和呕吐的建议,但他们的用药安全知识参差不齐。大多数 CPs 表示希望获得进一步的教育,以确保妇女能够获得可靠的信息和循证建议,从而优化病情管理。
{"title":"Nausea and vomiting in pregnancy: a cross-sectional study of community pharmacists in the UK.","authors":"Bradley Payne, Olivia Righton, Melanie Nana, Sarah Chapman, Catherine Williamson, Shivali Lakhani, Marsha Alter, Zoe Bell, Angela C Flynn","doi":"10.1093/ijpp/riae057","DOIUrl":"10.1093/ijpp/riae057","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the content and frequency of advice community pharmacists (CPs) provide to pregnant women with nausea and vomiting, their confidence in providing advice, and their knowledge of the safety of medication used to manage the condition.</p><p><strong>Methods: </strong>An online questionnaire of closed- and open-ended questions was distributed to CPs in the UK in May 2023. Closed-ended questions were analysed quantitatively, and conventional content analysis was utilised for open-ended responses.</p><p><strong>Key findings: </strong>One hundred and eighty-one respondents completed the questionnaire, 24 responses were excluded, leaving data from 157 available for analysis. The majority (90.4%) of participants reported having experience in providing advice on nausea and vomiting with varying levels of confidence. Advice provided included using over-the-counter products, lifestyle modifications, reassurance, medication advice, and referring to other healthcare professionals. Knowledge of first-line antiemetics considered safe in pregnancy varied; cyclizine was correctly identified as safe during pregnancy by 57.3%, followed by 37.6% for promethazine and 31.2% for prochlorperazine. Self-reported confidence and having experience providing advice were related to higher medication safety identification rates. Five percent of participants reported previous training on the condition, while 70% reported wanting further education, preferably delivered via an online medium.</p><p><strong>Conclusions: </strong>This study showed that although 90% of CPs provide advice on nausea and vomiting in pregnancy, their medication safety knowledge varied. The majority of CPs reported wanting further education that would ensure women could access reliable information and evidence-based advice to optimise management of the condition.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"45-51"},"PeriodicalIF":1.5,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rural pharmacist and consumer perspectives of expanded pharmacy services to address inequity in accessing health services. 农村药剂师和消费者对扩大药房服务以解决获得医疗服务不平等问题的看法。
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-07 DOI: 10.1093/ijpp/riae061
Selina Taylor, Martina Mylrea, Jai-Ann Eastaughffe, Rosemarie Dixon, Izabella Kent, Chloe Kappel, Beverley Glass

Objectives: Australians living in rural and remote communities have inadequate access to health services, contributing to poorer health outcomes compared to their metropolitan counterparts. This study investigated consumers' and pharmacists' perspectives of expanded pharmacy services in rural and remote communities in Australia. It aims to identify the role of the pharmacist in addressing the inequity of access to healthcare through the provision of expanded services in rural and remote practice.

Methods: A concurrent parallel mixed-methods study was undertaken in rural Western Queensland, Australia to include a survey of 167 consumers and in-depth interviews with 10 pharmacists. Quantitative data analysis employed descriptive statistics and chi-square tests, while qualitative data were analysed thematically against the constructs of the Diffusion of Innovations Theory.

Key findings: Consumers indicated that they would like to access weight management services (53%), whereas pharmacists thought it was important to offer respiratory clinics and services. Both pharmacists and consumers would like to see diabetes checks (30% and 56%, respectively) and vision, hearing, and ear checks (40% and 53%, respectively) implemented as services in community pharmacies. Most consumers (97%) believe pharmacists have the skills and knowledge to deliver expanded services and in doing so, they would improve the overall health of the community. Pharmacists reported staffing availability, workload and time constraints, cost, and jeopardizing inter-professional relationships as barriers to implementing expanded services.

Conclusions: Consumers were supportive of pharmacists working to their full scope of practice to provide expanded services, whereas pharmacists, while open to the idea, highlighted that there were barriers to overcome.

目标:生活在农村和偏远社区的澳大利亚人无法获得足够的医疗服务,导致他们的健康状况比大都市的人更差。本研究调查了消费者和药剂师对澳大利亚农村和偏远社区扩大药房服务的看法。研究旨在通过在农村和偏远地区提供扩展服务,确定药剂师在解决医疗服务不公平问题中的作用:方法:在澳大利亚昆士兰州西部农村地区同时开展了一项平行混合方法研究,包括对 167 名消费者的调查和对 10 名药剂师的深入访谈。定量数据分析采用了描述性统计和卡方检验,而定性数据则根据创新扩散理论的构造进行了专题分析:消费者表示他们希望获得体重管理服务(53%),而药剂师则认为提供呼吸门诊和服务非常重要。药剂师和消费者都希望社区药房能提供糖尿病检查(分别为 30% 和 56%)以及视力、听力和耳部检查(分别为 40% 和 53%)服务。大多数消费者(97%)认为药剂师拥有提供更多服务的技能和知识,这样做可以改善社区的整体健康水平。药剂师表示,人员可用性、工作量和时间限制、成本以及危害跨专业关系是实施扩展服务的障碍:消费者支持药剂师在其全部执业范围内提供扩展服务,而药剂师虽然对这一想法持开放态度,但强调需要克服一些障碍。
{"title":"Rural pharmacist and consumer perspectives of expanded pharmacy services to address inequity in accessing health services.","authors":"Selina Taylor, Martina Mylrea, Jai-Ann Eastaughffe, Rosemarie Dixon, Izabella Kent, Chloe Kappel, Beverley Glass","doi":"10.1093/ijpp/riae061","DOIUrl":"10.1093/ijpp/riae061","url":null,"abstract":"<p><strong>Objectives: </strong>Australians living in rural and remote communities have inadequate access to health services, contributing to poorer health outcomes compared to their metropolitan counterparts. This study investigated consumers' and pharmacists' perspectives of expanded pharmacy services in rural and remote communities in Australia. It aims to identify the role of the pharmacist in addressing the inequity of access to healthcare through the provision of expanded services in rural and remote practice.</p><p><strong>Methods: </strong>A concurrent parallel mixed-methods study was undertaken in rural Western Queensland, Australia to include a survey of 167 consumers and in-depth interviews with 10 pharmacists. Quantitative data analysis employed descriptive statistics and chi-square tests, while qualitative data were analysed thematically against the constructs of the Diffusion of Innovations Theory.</p><p><strong>Key findings: </strong>Consumers indicated that they would like to access weight management services (53%), whereas pharmacists thought it was important to offer respiratory clinics and services. Both pharmacists and consumers would like to see diabetes checks (30% and 56%, respectively) and vision, hearing, and ear checks (40% and 53%, respectively) implemented as services in community pharmacies. Most consumers (97%) believe pharmacists have the skills and knowledge to deliver expanded services and in doing so, they would improve the overall health of the community. Pharmacists reported staffing availability, workload and time constraints, cost, and jeopardizing inter-professional relationships as barriers to implementing expanded services.</p><p><strong>Conclusions: </strong>Consumers were supportive of pharmacists working to their full scope of practice to provide expanded services, whereas pharmacists, while open to the idea, highlighted that there were barriers to overcome.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"73-80"},"PeriodicalIF":1.5,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142620200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspectives of Malaysian community pharmacists on challenges and barriers to smoking cessation programme: a qualitative study. 马来西亚社区药剂师对戒烟计划面临的挑战和障碍的看法:一项定性研究。
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-07 DOI: 10.1093/ijpp/riae066
Ee Lee Lio, Mari Kannan Maharajan, Kingston Rajiah

Objectives: Smoking remains a significant public health concern, necessitating effective smoking cessation interventions. This study explores the barriers community pharmacists face in delivering smoking cessation services in Malaysia and potential solutions to improve their contribution to public health.

Methods: This qualitative study employed purposive and snowball sampling to recruit community pharmacists in Malaysia. Semi-structured interviews were conducted, exploring pharmacists' perspectives on barriers, counselling approaches, follow-up strategies, and opinions on smoking cessation services. Thematic analysis was employed to identify key themes and sub-themes.

Key findings: Three main themes emerged from the data analysis: barriers, counselling and enhancing follow-up, and pharmacists' opinions on professional fees. Under the theme of barriers, sub-themes included underutilization by the public, poor follow-up by customers, time constraints, lack of educational materials and support, and customer perception. The counselling and enhancing follow-up theme encompassed shared decision-making, motivational intervention, follow-up via phone calls or messaging apps, and providing rebate vouchers. Pharmacists' opinions on professional fees revealed mixed perspectives, with some advocating for fees to recognize the professional service provided, while others expressed concerns about access barriers.

Conclusions: Community pharmacists face challenges in delivering smoking cessation services, such as underutilization, poor follow-up, time constraints, and affordability. However, strategies like shared decision-making and proactive communication can enhance effectiveness. Addressing professional fees and collaborative efforts are essential to optimising these services.

目标:吸烟仍然是一个重大的公共卫生问题,需要采取有效的戒烟干预措施。本研究探讨了马来西亚社区药剂师在提供戒烟服务时面临的障碍,以及改善其对公共卫生贡献的潜在解决方案:这项定性研究采用了目的性抽样和滚雪球抽样的方法来招募马来西亚的社区药剂师。研究人员进行了半结构式访谈,探讨了药剂师对戒烟服务的障碍、咨询方法、后续策略和意见的看法。采用主题分析法确定了关键主题和次主题:数据分析得出了三大主题:障碍、辅导和加强随访,以及药剂师对专业收费的看法。在 "障碍 "这一主题下,次主题包括公众使用不足、顾客跟进不力、时间限制、缺乏教育材料和支持,以及顾客的看法。辅导和加强跟进主题包括共同决策、激励干预、通过电话或信息应用程序跟进,以及提供回扣券。药剂师对专业收费的看法不一,一些药剂师主张收费是对所提供专业服务的认可,而另一些药剂师则对收费障碍表示担忧:结论:社区药剂师在提供戒烟服务时面临着各种挑战,如利用率低、跟踪不力、时间限制和经济承受能力等。然而,共同决策和主动沟通等策略可以提高服务效率。要优化这些服务,就必须解决专业收费问题并开展合作。
{"title":"Perspectives of Malaysian community pharmacists on challenges and barriers to smoking cessation programme: a qualitative study.","authors":"Ee Lee Lio, Mari Kannan Maharajan, Kingston Rajiah","doi":"10.1093/ijpp/riae066","DOIUrl":"10.1093/ijpp/riae066","url":null,"abstract":"<p><strong>Objectives: </strong>Smoking remains a significant public health concern, necessitating effective smoking cessation interventions. This study explores the barriers community pharmacists face in delivering smoking cessation services in Malaysia and potential solutions to improve their contribution to public health.</p><p><strong>Methods: </strong>This qualitative study employed purposive and snowball sampling to recruit community pharmacists in Malaysia. Semi-structured interviews were conducted, exploring pharmacists' perspectives on barriers, counselling approaches, follow-up strategies, and opinions on smoking cessation services. Thematic analysis was employed to identify key themes and sub-themes.</p><p><strong>Key findings: </strong>Three main themes emerged from the data analysis: barriers, counselling and enhancing follow-up, and pharmacists' opinions on professional fees. Under the theme of barriers, sub-themes included underutilization by the public, poor follow-up by customers, time constraints, lack of educational materials and support, and customer perception. The counselling and enhancing follow-up theme encompassed shared decision-making, motivational intervention, follow-up via phone calls or messaging apps, and providing rebate vouchers. Pharmacists' opinions on professional fees revealed mixed perspectives, with some advocating for fees to recognize the professional service provided, while others expressed concerns about access barriers.</p><p><strong>Conclusions: </strong>Community pharmacists face challenges in delivering smoking cessation services, such as underutilization, poor follow-up, time constraints, and affordability. However, strategies like shared decision-making and proactive communication can enhance effectiveness. Addressing professional fees and collaborative efforts are essential to optimising these services.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"58-63"},"PeriodicalIF":1.5,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142739341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why go back?: Advantages and challenges of longitudinal qualitative research in social pharmacy, and recommendations for social pharmacy researchers. 为什么要回去?:社会药学纵向定性研究的优势与挑战,以及对社会药学研究者的建议。
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-07 DOI: 10.1093/ijpp/riae072
Pauline Norris, Molly George, Vanda Symon, Shirley Keown, Lauralie Richard, Sandhaya Sandy Bhawan, Rosalina Richards

Objectives: Although most qualitative research is cross-sectional, particularly in social pharmacy/pharmacy practice, there are many advantages of using a longitudinal qualitative research (LQR) design, i.e. re-interviewing participants over a period of time.

Methods: This paper describes some advantages and challenges of LQR using our 'Access to Medicines: Exploring Lived Experience to inform policy and programmes' study as an illustration.

Key findings: Advantages of LQR include obtaining richer and more complete data, providing a greater understanding of change and lack of change, understanding pathways through complex systems, including people facing difficult social circumstances, and contributing to evaluation research. Challenges to be addressed include the implications of developing friendships with participants, deciding whether to assist participants, maintaining participant anonymity, the impact of the research on the researchers, and how to analyse the large volume of data generated.

Conclusions: We recommend piloting methods before starting a study, considering the resource implications of LQR, planning the analysis in advance, planning for how to deal with developing friendships with participants, considering threats to participant anonymity, and supporting researchers doing fieldwork.

目的:虽然大多数定性研究都是横断面研究,尤其是在社会药学/药房实践中,但采用纵向定性研究(LQR)设计,即在一段时间内重新访谈参与者,有很多优势:本文介绍了使用我们的 "药品获取途径 "进行 LQR 的一些优势和挑战:方法:本文以我们的 "获取药品:探索生活经验,为政策和计划提供信息 "研究为例来说明 LQR 的优势和挑战:主要发现:生活质量报告的优势包括:获得更丰富、更完整的数据;更深入地了解变化和缺乏变化的情况;了解通过复杂系统的途径,包括面临困难社会环境的人,以及为评估研究做出贡献。需要应对的挑战包括与参与者建立友谊的影响、决定是否帮助参与者、维护参与者的匿名性、研究对研究人员的影响以及如何分析产生的大量数据:我们建议在开始研究之前先试用各种方法,考虑 LQR 所涉及的资源问题,提前规划分析工作,规划如何处理与参与者建立友谊的问题,考虑对参与者匿名性的威胁,并为开展实地工作的研究人员提供支持。
{"title":"Why go back?: Advantages and challenges of longitudinal qualitative research in social pharmacy, and recommendations for social pharmacy researchers.","authors":"Pauline Norris, Molly George, Vanda Symon, Shirley Keown, Lauralie Richard, Sandhaya Sandy Bhawan, Rosalina Richards","doi":"10.1093/ijpp/riae072","DOIUrl":"10.1093/ijpp/riae072","url":null,"abstract":"<p><strong>Objectives: </strong>Although most qualitative research is cross-sectional, particularly in social pharmacy/pharmacy practice, there are many advantages of using a longitudinal qualitative research (LQR) design, i.e. re-interviewing participants over a period of time.</p><p><strong>Methods: </strong>This paper describes some advantages and challenges of LQR using our 'Access to Medicines: Exploring Lived Experience to inform policy and programmes' study as an illustration.</p><p><strong>Key findings: </strong>Advantages of LQR include obtaining richer and more complete data, providing a greater understanding of change and lack of change, understanding pathways through complex systems, including people facing difficult social circumstances, and contributing to evaluation research. Challenges to be addressed include the implications of developing friendships with participants, deciding whether to assist participants, maintaining participant anonymity, the impact of the research on the researchers, and how to analyse the large volume of data generated.</p><p><strong>Conclusions: </strong>We recommend piloting methods before starting a study, considering the resource implications of LQR, planning the analysis in advance, planning for how to deal with developing friendships with participants, considering threats to participant anonymity, and supporting researchers doing fieldwork.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"113-118"},"PeriodicalIF":1.5,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142822149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The International Collaboration of Pharmacy Journal Editors (ICPJE) formally constituted to foster quality around clinical and social pharmacy practice research publications.
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-07 DOI: 10.1093/ijpp/riaf001
F Alves da Costa, F Fernandez-Llimos, S Desselle, I Arnet, Z Babar, C Bond, M Cordina, V Garcia Cardenas, M S El Hajj, R Jacobsen, A V Law, L S Nørgaard, C Polidori, N Shcherbakova, D Stewart, F Tonin, A E Weidmann
{"title":"The International Collaboration of Pharmacy Journal Editors (ICPJE) formally constituted to foster quality around clinical and social pharmacy practice research publications.","authors":"F Alves da Costa, F Fernandez-Llimos, S Desselle, I Arnet, Z Babar, C Bond, M Cordina, V Garcia Cardenas, M S El Hajj, R Jacobsen, A V Law, L S Nørgaard, C Polidori, N Shcherbakova, D Stewart, F Tonin, A E Weidmann","doi":"10.1093/ijpp/riaf001","DOIUrl":"https://doi.org/10.1093/ijpp/riaf001","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":"33 1","pages":"3-5"},"PeriodicalIF":1.5,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fostering consensus for the implementation of a clinical pharmacy specialization: a nominal group technique approach with pharmacy stakeholders. 促进共识的实施临床药学专业化:名义团体技术方法与药房利益相关者。
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-07 DOI: 10.1093/ijpp/riae076
Laura Moura, Stephane Steurbaut, Helder Mota Filipe, Filipa Alves da Costa

Objectives: To explore the need for a specialization in clinical pharmacy and the model to be adopted, as perceived by Portuguese stakeholders.

Methods: A nominal group technique through two online meetings addressed four questions: pros and cons of specialization models used internationally; preferred model for Portugal; and success factors for implementation.

Key findings: All nine stakeholders recognized the need to train pharmacists in clinical pharmacy and agreed specialization is essential, through a model including strong clinical undergraduate education, supplemented with postgraduate training. The postgraduate component considered most suited comprised a balanced approach to theoretical and practical training, where the relative weigh of theory (20%-60%) could progressively decrease with the implementation of the European directive 2024/782 establishing the minimum training requirements for the professions of pharmacists, where the clinical pharmacy is to be strengthened at the undergraduate level. Success factors for implementing this model include, establishing a regulatory framework for the career and the desired characteristics of the graduates from the postgraduate programme.

Conclusions: This study led to a consensus among key Portuguese stakeholders on the model to be adopted for a clinical pharmacy specialization in Portugal and, the information gathered will be used to guide future implementation.

目的:探讨需要在临床药学专业化和模式被采用,由葡萄牙利益相关者感知。方法:通过两次在线会议,采用名义小组技术解决了四个问题:国际上使用的专业化模型的利弊;葡萄牙的首选模式;以及实施的成功因素。主要发现:所有九个利益攸关方都认识到有必要培训临床药学的药剂师,并同意通过包括强有力的临床本科教育,辅以研究生培训的模式,实现专业化是必不可少的。研究生部分被认为是最合适的,包括理论和实践培训的平衡方法,其中理论的相对权重(20%-60%)可以随着欧洲指令2024/782的实施而逐步减少,该指令建立了药剂师职业的最低培训要求,其中临床药学将在本科阶段得到加强。实施这一模式的成功因素包括:为研究生课程的毕业生建立职业管理框架和期望的特点。结论:这项研究导致了关键的葡萄牙利益相关者之间的共识,在葡萄牙临床药学专业化采用的模式,收集的信息将用于指导未来的实施。
{"title":"Fostering consensus for the implementation of a clinical pharmacy specialization: a nominal group technique approach with pharmacy stakeholders.","authors":"Laura Moura, Stephane Steurbaut, Helder Mota Filipe, Filipa Alves da Costa","doi":"10.1093/ijpp/riae076","DOIUrl":"10.1093/ijpp/riae076","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the need for a specialization in clinical pharmacy and the model to be adopted, as perceived by Portuguese stakeholders.</p><p><strong>Methods: </strong>A nominal group technique through two online meetings addressed four questions: pros and cons of specialization models used internationally; preferred model for Portugal; and success factors for implementation.</p><p><strong>Key findings: </strong>All nine stakeholders recognized the need to train pharmacists in clinical pharmacy and agreed specialization is essential, through a model including strong clinical undergraduate education, supplemented with postgraduate training. The postgraduate component considered most suited comprised a balanced approach to theoretical and practical training, where the relative weigh of theory (20%-60%) could progressively decrease with the implementation of the European directive 2024/782 establishing the minimum training requirements for the professions of pharmacists, where the clinical pharmacy is to be strengthened at the undergraduate level. Success factors for implementing this model include, establishing a regulatory framework for the career and the desired characteristics of the graduates from the postgraduate programme.</p><p><strong>Conclusions: </strong>This study led to a consensus among key Portuguese stakeholders on the model to be adopted for a clinical pharmacy specialization in Portugal and, the information gathered will be used to guide future implementation.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"127-130"},"PeriodicalIF":1.5,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142921757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune checkpoint inhibitors in cancer patients from the perspective of pharmaceutical care: a scoping review. 从药物治疗的角度看癌症患者使用免疫检查点抑制剂:范围界定综述。
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-07 DOI: 10.1093/ijpp/riae054
Giselle Amorim Lira, Júlia de Andrade Brandão, Leticia Anderson, Ênio José Bassi

Background: Cancer treatment has become a significant health challenge, with notable changes in recent years due to increasing knowledge of cancer biology. The use of immune checkpoint inhibitors (ICIs) has shown promising results, but they can induce adverse events (AEs), resulting in serious consequences for patients. Pharmaceutical care aims to prevent, identify, and address issues related to medications, such as AEs.

Aim: The objective of this scoping review was to assess the contribution of pharmacists to the intervention and care of cancer patients undergoing treatment with ICIs.

Methods: The PubMed, Scopus, Embase, and Web of Science databases were searched for studies on the treatment of cancer patients treated with ICIs in which pharmacists participated. No time frame or language restriction was applied. Article screening was performed independently by two authors, with any discrepancies resolved by a third author. The studies were analyzed and included in this review following the inclusion and exclusion criteria.

Results: Nine studies fulfilled the inclusion criteria. Pharmaceutical care encompasses a variety of interventions, including providing guidance to patients and to the multidisciplinary team, monitoring and managing AEs, conducting pharmaceutical consultations, and recommending over-the-counter medications and laboratory tests, among other actions. Pharmaceutical recommendations led to better outcomes regarding AEs.

Conclusions: Pharmaceutical care has a positive impact on oncological immunotherapy with ICIs, contributing to both health institutions through cost reduction and, most importantly, patients by improving treatment outcomes and enhancing the quality of life.

背景:癌症治疗已成为一项重大的健康挑战,近年来,由于对癌症生物学的认识不断加深,癌症治疗发生了显著变化。免疫检查点抑制剂(ICIs)的使用已显示出良好的效果,但它们可能诱发不良事件(AEs),给患者造成严重后果。药学护理旨在预防、识别和解决与药物有关的问题,如 AEs。目的:本范围综述旨在评估药剂师对接受 ICIs 治疗的癌症患者的干预和护理所做的贡献:方法:在 PubMed、Scopus、Embase 和 Web of Science 数据库中搜索药剂师参与的有关癌症患者接受 ICIs 治疗的研究。没有时间或语言限制。文章筛选由两位作者独立完成,任何不一致之处由第三位作者解决。按照纳入和排除标准对研究进行分析并纳入本综述:九项研究符合纳入标准。药物护理包含多种干预措施,包括为患者和多学科团队提供指导、监测和管理AE、进行药物咨询、推荐非处方药和实验室检查等。药物建议可改善AEs的治疗效果:结论:药物治疗对使用 ICIs 的肿瘤免疫疗法有积极影响,可通过降低成本为医疗机构做出贡献,最重要的是,可通过改善治疗效果和提高生活质量为患者做出贡献。
{"title":"Immune checkpoint inhibitors in cancer patients from the perspective of pharmaceutical care: a scoping review.","authors":"Giselle Amorim Lira, Júlia de Andrade Brandão, Leticia Anderson, Ênio José Bassi","doi":"10.1093/ijpp/riae054","DOIUrl":"10.1093/ijpp/riae054","url":null,"abstract":"<p><strong>Background: </strong>Cancer treatment has become a significant health challenge, with notable changes in recent years due to increasing knowledge of cancer biology. The use of immune checkpoint inhibitors (ICIs) has shown promising results, but they can induce adverse events (AEs), resulting in serious consequences for patients. Pharmaceutical care aims to prevent, identify, and address issues related to medications, such as AEs.</p><p><strong>Aim: </strong>The objective of this scoping review was to assess the contribution of pharmacists to the intervention and care of cancer patients undergoing treatment with ICIs.</p><p><strong>Methods: </strong>The PubMed, Scopus, Embase, and Web of Science databases were searched for studies on the treatment of cancer patients treated with ICIs in which pharmacists participated. No time frame or language restriction was applied. Article screening was performed independently by two authors, with any discrepancies resolved by a third author. The studies were analyzed and included in this review following the inclusion and exclusion criteria.</p><p><strong>Results: </strong>Nine studies fulfilled the inclusion criteria. Pharmaceutical care encompasses a variety of interventions, including providing guidance to patients and to the multidisciplinary team, monitoring and managing AEs, conducting pharmaceutical consultations, and recommending over-the-counter medications and laboratory tests, among other actions. Pharmaceutical recommendations led to better outcomes regarding AEs.</p><p><strong>Conclusions: </strong>Pharmaceutical care has a positive impact on oncological immunotherapy with ICIs, contributing to both health institutions through cost reduction and, most importantly, patients by improving treatment outcomes and enhancing the quality of life.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"19-33"},"PeriodicalIF":1.5,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Environmental sustainability-an essential component of rational use of medicines. 环境可持续性--合理用药的重要组成部分。
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-07 DOI: 10.1093/ijpp/riae073
Valentina Giunchi, Michele Fusaroli, Elkanah Linder, Johanna Villén, Emanuel Raschi, Carlotta Lunghi, Björn Wettermark, Elisabetta Poluzzi, Marmar Nekoro

Human-use medicines are introduced into surface water throughout their entire life cycle, from manufacturing and consumption to improper disposal, resulting in negative effects on aquatic flora and fauna. Sustainability approaches have addressed this issue, proposing frameworks like the One Health approach. A revised definition of the rational use of medicines has also been proposed, taking into account their environmental sustainability. Building on this updated definition, this paper presents a decision-making flowchart to integrate the assessment of the impact of human medicines on surface water, outlining existing actions and proposing new ones. These actions are categorized into those with primary clinical benefits and those focused solely on environmental concerns. They include both upstream and downstream measures, such as implementing regulations similar to those in the EU and the USA, educating future healthcare practitioners, promoting green pharmacy innovations, and establishing proper disposal practices.

人用药物在其整个生命周期(从生产和消费到不当处置)中被引入地表水,对水生动植物造成负面影响。可持续性方法解决了这一问题,提出了“同一个健康”方法等框架。考虑到药物的环境可持续性,还提出了合理使用药物的修订定义。在这一更新定义的基础上,本文提出了一个决策流程图,以综合评估人类药物对地表水的影响,概述现有行动并提出新的行动。这些行动可分为具有主要临床效益的行动和仅关注环境问题的行动。它们包括上游和下游措施,例如实施与欧盟和美国类似的法规,教育未来的医疗保健从业者,促进绿色药房创新,以及建立适当的处理实践。
{"title":"Environmental sustainability-an essential component of rational use of medicines.","authors":"Valentina Giunchi, Michele Fusaroli, Elkanah Linder, Johanna Villén, Emanuel Raschi, Carlotta Lunghi, Björn Wettermark, Elisabetta Poluzzi, Marmar Nekoro","doi":"10.1093/ijpp/riae073","DOIUrl":"10.1093/ijpp/riae073","url":null,"abstract":"<p><p>Human-use medicines are introduced into surface water throughout their entire life cycle, from manufacturing and consumption to improper disposal, resulting in negative effects on aquatic flora and fauna. Sustainability approaches have addressed this issue, proposing frameworks like the One Health approach. A revised definition of the rational use of medicines has also been proposed, taking into account their environmental sustainability. Building on this updated definition, this paper presents a decision-making flowchart to integrate the assessment of the impact of human medicines on surface water, outlining existing actions and proposing new ones. These actions are categorized into those with primary clinical benefits and those focused solely on environmental concerns. They include both upstream and downstream measures, such as implementing regulations similar to those in the EU and the USA, educating future healthcare practitioners, promoting green pharmacy innovations, and establishing proper disposal practices.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"102-112"},"PeriodicalIF":1.5,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142909662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge, attitudes, and practices of community pharmacists providing over-the-counter emergency hormonal contraception: a scoping review. 提供非处方紧急荷尔蒙避孕药的社区药剂师的知识、态度和做法:范围界定综述。
IF 1.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-07 DOI: 10.1093/ijpp/riae062
Ruth A Nona, Robin A Ray, Selina M Taylor, Beverley D Glass

Objectives: Reducing the rate and impact of unintended pregnancy through effective contraception is a public health goal. Since deregulation, globally, ease of access to community pharmacists has enabled them to play a key role in the provision of emergency hormonal contraceptive pills (ECP). The aim of this scoping review is to explore pharmacists' overall knowledge of and attitudes and practices towards the provision of emergency contraception.

Methods: A systematic literature search for the period from 1999 to 2023 was conducted using Scopus, Medline (Ovid), CINAHL, Emcare, Web of Science, and Google Scholar. Keywords such as emergency contraception, emergency contraceptive, morning after pill, plan B, pharmacist, community pharmacist, and pharmacy were applied. Articles published only in English that described the knowledge, attitudes, and practices of community pharmacists providing emergency contraception were included in this review.

Key findings: Twenty studies met the inclusion criteria. Despite positive attitudes towards the provision of ECP, there is a clear deficit in both the knowledge and counselling practices of pharmacists, with some pharmacists lacking an open attitude towards the supply of ECP to adolescents and third parties. Usage of a private counselling area ranged from 0% to 90% highlighting privacy for patients seeking ECPs is lacking during consultations. In countries where practice guidelines are available, these are often not being optimally utilized.

Conclusions: This review has highlighted gaps in pharmacists' knowledge and counselling practices, demonstrating shortcomings in pharmacists' education, training, and application of professional practice guidelines. Future research on ECP guidelines is recommended to improve implementation and usability in practice.

目标:通过有效的避孕措施降低意外怀孕的发生率和影响是一项公共卫生目标。在全球范围内,自解除管制以来,社区药剂师在提供紧急荷尔蒙避孕药 (ECP) 方面发挥了重要作用。本综述旨在探讨药剂师对提供紧急避孕药的总体认识、态度和做法:使用 Scopus、Medline (Ovid)、CINAHL、Emcare、Web of Science 和 Google Scholar 对 1999 年至 2023 年期间的文献进行了系统检索。关键词包括紧急避孕、紧急避孕药、事后避孕药、B 计划、药剂师、社区药剂师和药房。本综述收录了仅以英文发表的描述社区药剂师提供紧急避孕药具的知识、态度和实践的文章:20 项研究符合纳入标准。尽管药剂师对提供 ECP 持积极态度,但在知识和咨询实践方面存在明显不足,一些药剂师对向青少年和第三方提供 ECP 缺乏开放态度。私人咨询区的使用率从 0% 到 90% 不等,这表明在咨询过程中,寻求 ECP 的患者缺乏隐私。在有实践指南的国家,这些指南往往没有得到充分利用:本综述强调了药剂师在知识和咨询实践方面的差距,表明药剂师在教育、培训和应用专业实践指南方面存在不足。建议今后对 ECP 指南进行研究,以改进实践中的实施和可用性。
{"title":"Knowledge, attitudes, and practices of community pharmacists providing over-the-counter emergency hormonal contraception: a scoping review.","authors":"Ruth A Nona, Robin A Ray, Selina M Taylor, Beverley D Glass","doi":"10.1093/ijpp/riae062","DOIUrl":"10.1093/ijpp/riae062","url":null,"abstract":"<p><strong>Objectives: </strong>Reducing the rate and impact of unintended pregnancy through effective contraception is a public health goal. Since deregulation, globally, ease of access to community pharmacists has enabled them to play a key role in the provision of emergency hormonal contraceptive pills (ECP). The aim of this scoping review is to explore pharmacists' overall knowledge of and attitudes and practices towards the provision of emergency contraception.</p><p><strong>Methods: </strong>A systematic literature search for the period from 1999 to 2023 was conducted using Scopus, Medline (Ovid), CINAHL, Emcare, Web of Science, and Google Scholar. Keywords such as emergency contraception, emergency contraceptive, morning after pill, plan B, pharmacist, community pharmacist, and pharmacy were applied. Articles published only in English that described the knowledge, attitudes, and practices of community pharmacists providing emergency contraception were included in this review.</p><p><strong>Key findings: </strong>Twenty studies met the inclusion criteria. Despite positive attitudes towards the provision of ECP, there is a clear deficit in both the knowledge and counselling practices of pharmacists, with some pharmacists lacking an open attitude towards the supply of ECP to adolescents and third parties. Usage of a private counselling area ranged from 0% to 90% highlighting privacy for patients seeking ECPs is lacking during consultations. In countries where practice guidelines are available, these are often not being optimally utilized.</p><p><strong>Conclusions: </strong>This review has highlighted gaps in pharmacists' knowledge and counselling practices, demonstrating shortcomings in pharmacists' education, training, and application of professional practice guidelines. Future research on ECP guidelines is recommended to improve implementation and usability in practice.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"6-18"},"PeriodicalIF":1.5,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142644100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1